Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Ozempic and other GLP-1 drugs are generating headlines for supposedly preventing cancer, but current evidence does not justify that claim. Large observational studies hint at reduced risks for some…
Read the full articleYou might also wanna read
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Could Ozempic Lower Breast Cancer Risk? What to Know
Doctors weigh in on promising new data.
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those takin
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
forbes.com·1mo agoGLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.
Systematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefits
A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility impro

Comments
Sign in to join the conversation.
No comments yet. Be the first.